Glimitaz GP2 combines Glimepiride, Pioglitazone, and Metformin Hydrochloride (SR) to provide effective glycemic control in type 2 diabetes mellitus. This triple therapy works synergistically to enhance insulin sensitivity, regulate blood glucose levels, and minimize the risk of diabetes-related complications.
Tablets
Glimitaz GP2 – Glimepiride, Pioglitazone & Metformin SR Tablets
₹125.00
Glimitaz GP2 combines Glimepiride, Pioglitazone, and Metformin SR to provide comprehensive glycemic control with improved insulin sensitivity in type 2 diabetes management.
Availability: 100 in stock
Reviews
There are no reviews yet.